Sort
39,280 grants matching “leukemia”
Enhancer Driven Gene Regulation During Lymphocyte Development
$525,166Jane Amanda Skok · New York University School Of Medicine · R01 · FY2014 · GM
Enhancer Driven Gene Regulation During Lymphocyte Development
$525,166Jane Amanda Skok · New York University School Of Medicine · R01 · FY2016 · GM
Using spatial, single-cell genomic recording to investigate age-associated clonal hematopoiesis
$525,137Rong Lu · University Of Southern California · R01 · FY2024 · AG
Tumor Microenvironment in Cancer Progression
$525,122Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$525,083Phillip G Febbo · University Of California, San Francisco · U01 · FY2012 · CA
OCG Data Coordinating Center
$525,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
OCG Data Coordinating Center
$525,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
$524,951Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$524,782Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Role of the TET1 short isoform in MDS development and maintenance
$524,779Zhijian Qian · University Of Florida · R01 · FY2024 · HL
STAG2 mutations and 3D genome organization in glioblastoma multiforme
$524,737Todd A Waldman · Georgetown University · R01 · FY2023 · CA
Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-
$524,715Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$524,636Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
$524,636Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Fate of Spermatogonial Stem Cells
$524,611Georgetown University · R01 · FY2004 · HD
Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV Model
$524,469Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2010 · AI
DEVELOPMENTAL FUNDS
$524,426John H. Glick · University Of Pennsylvania · P30 · FY2008 · CA
Cell migration and cell-cell interactions in bone marrow
$524,412Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2010 · HL
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia
$524,381Jian Huang · Coriell Institute For Medical Research · R01 · FY2022 · HL
BUILDING A RAPID DRUG DISCOVERY PIPELINE SPECIFIC FOR PEDIATRIC ACUTE MYELOGENOUS LEUKEMIA WITH MACHINE LEARNING/IN VITRO FEEDBACK LOOPS
$524,340The Research Institute Of The Mcgill University Health Centre · · FY2025 · Defense Health Agency
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
$524,156Laura Maria Calvi · University Of Rochester · R01 · FY2025 · AG
Regulation of the Fanconi Anemia Pathway by Ubiquitination
$524,141Alan David D'andrea · Dana-Farber Cancer Inst · R01 · FY2012 · DK
Towards rational design of combination therapeutic targets
$524,014Kai Tan · Children'S Hosp Of Philadelphia · U01 · FY2022 · CA
CHANGING PARENTAL BELIEFS IN PEDIATRICS ONCOLOGY
$523,997Childrens Hospital Of Philadelphia · R01 · FY2005 · CA
Novel CART Cells for Treating AML
$523,923Xianxin Hua · University Of Pennsylvania · R01 · FY2022 · CA